Michael Rocco to Clinical Trials as Topic
This is a "connection" page, showing publications Michael Rocco has written about Clinical Trials as Topic.
Connection Strength
0.458
-
O'Lone E, Howell M, Viecelli AK, Craig JC, Tong A, Sautenet B, Herrington WG, Herzog CA, Jafar TH, Jardine M, Krane V, Levin A, Malyszko J, Rocco MV, Strippoli G, Tonelli M, Wang AY, Wanner C, Zannad F, Winkelmayer WC, Wheeler DC. Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals. Nephrol Dial Transplant. 2020 10 01; 35(10):1761-1769.
Score: 0.161
-
O'Lone E, Viecelli AK, Craig JC, Tong A, Sautenet B, Herrington WG, Herzog CA, Jafar TH, Jardine M, Krane V, Levin A, Malyszko J, Rocco MV, Strippoli G, Tonelli M, Wang AYM, Wanner C, Zannad F, Winkelmayer WC, Wheeler DC. Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop. Am J Kidney Dis. 2020 07; 76(1):109-120.
Score: 0.156
-
Levin NW, Raimann JG, Rocco MV. Should the knowledge gained from the Frequent Hemodialysis Network (FHN) trials change dialysis practice? Curr Opin Nephrol Hypertens. 2011 Nov; 20(6):577-82.
Score: 0.087
-
Rocco MV, Cheung AK, Greene T, Eknoyan G. The HEMO Study: applicability and generalizability. Nephrol Dial Transplant. 2005 Feb; 20(2):278-84.
Score: 0.054